Cf. Bourgeois et al., Identification of a bidirectional splicing enhancer: Differential involvement of SR proteins in 5 ' or 3 ' splice site activation, MOL CELL B, 19(11), 1999, pp. 7347-7356
The adenovirus E1A pre-mRNA undergoes alternative splicing whose modulation
occurs during infection, through the use of three different 5' splice site
s and of one major or one minor 3' splice site. Although this pre-mRNA has
been extensively used as a model to compare the transactivation properties
of SR proteins, no cis-acting element has been identified in the transcript
sequence; Here we describe the identification and the characterization of
a purine-rich splicing enhancer, located just upstream of the 12S 5' splice
site, which is formed from two contiguous 9-nucleotide (nt) purine motifs
(Pu1 and Pu2). We demonstrate that this sequence is a bidirectional splicin
g enhancer (BSE) in vivo and in vitro, because it activates both the downst
ream 12S 5' splice site through the Pul motif and the upstream 216-nt inter
vening sequence (IVS) 3' splice site through both motifs. UV cross-linking
and immunoprecipitation experiments indicate that the BSE interacts with se
veral SR proteins specifically, among them 9G8 and ASF/SF2, which bind pref
erentially to the Pul and Pu2 motifs, respectively. Interestingly, we show
by in vitro complementation assays that SR proteins have distinct transacti
vatory properties. In particular, 9G8, but not ASF/SF2, or SC35, is able to
strongly activate the recognition of the 12S 5' splice site in a BSE-depen
dent manner in wild-type E1A or in a heterologous context, whereas ASF/SF2
or SC35, but not 9G8, activates the upstream 216-nt IVS splicing. Thus, our
results identify a novel exonic BSE and the SR proteins which are involved
in its differential activity.